AU1228499A - Application of tnf antagonists as medicaments for treating septic diseases - Google Patents

Application of tnf antagonists as medicaments for treating septic diseases

Info

Publication number
AU1228499A
AU1228499A AU12284/99A AU1228499A AU1228499A AU 1228499 A AU1228499 A AU 1228499A AU 12284/99 A AU12284/99 A AU 12284/99A AU 1228499 A AU1228499 A AU 1228499A AU 1228499 A AU1228499 A AU 1228499A
Authority
AU
Australia
Prior art keywords
medicaments
application
tnf antagonists
treating septic
septic diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU12284/99A
Other versions
AU756167B2 (en
Inventor
Lothar Daum
Jurgen Eiselstein
Martin Kaul
Joachim Kempeni
Hartmut Kupper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG
Publication of AU1228499A publication Critical patent/AU1228499A/en
Application granted granted Critical
Publication of AU756167B2 publication Critical patent/AU756167B2/en
Assigned to ABBOTT GMBH & CO. KG reassignment ABBOTT GMBH & CO. KG Alteration of Name(s) of Applicant(s) under S113 Assignors: KNOLL AKTIENGESELLSCHAFT
Anticipated expiration legal-status Critical
Withdrawn - After Issue legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU12284/99A 1997-10-23 1998-10-15 Application of TNF antagonists as medicaments for treating septic diseases Withdrawn - After Issue AU756167B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19746868 1997-10-23
DE19746868A DE19746868A1 (en) 1997-10-23 1997-10-23 Use of tumour necrosis factor antagonists
PCT/EP1998/006545 WO1999021582A2 (en) 1997-10-23 1998-10-15 Application of tnf antagonists as medicaments for treating septic diseases

Publications (2)

Publication Number Publication Date
AU1228499A true AU1228499A (en) 1999-05-17
AU756167B2 AU756167B2 (en) 2003-01-09

Family

ID=7846420

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12284/99A Withdrawn - After Issue AU756167B2 (en) 1997-10-23 1998-10-15 Application of TNF antagonists as medicaments for treating septic diseases

Country Status (13)

Country Link
EP (1) EP1024831A2 (en)
JP (1) JP2001521009A (en)
KR (1) KR20010024549A (en)
CN (1) CN1163272C (en)
AU (1) AU756167B2 (en)
BR (1) BR9813114A (en)
CA (1) CA2306790A1 (en)
DE (1) DE19746868A1 (en)
HU (1) HUP0100105A3 (en)
IL (1) IL135083A0 (en)
NO (1) NO20001894L (en)
WO (1) WO1999021582A2 (en)
ZA (1) ZA989615B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (en) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
UA76640C2 (en) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Method for correcting pathological immune responses and homeopathic medicinal agent
UA76639C2 (en) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medication and method for treating erectile dysfunctions
RU2309732C1 (en) 2006-03-13 2007-11-10 Олег Ильич Эпштейн Pressed solid oral formulation of medicinal preparation and method for preparing solid oral formulation of medicinal preparation
FR2962651A1 (en) 2010-07-15 2012-01-20 Oleg Iliich Epshtein PHARMACEUTICAL ASSOCIATION COMPOSITION AND ITS USE IN METHODS FOR TREATING FUNCTIONAL DISEASES OR DISORDERS OF THE GASTROINTESTINAL TRACT
US9308275B2 (en) 2010-07-15 2016-04-12 Oleg Iliich Epshtein Method of increasing the effect of an activated-potentiated form of an antibody
EP2415461B1 (en) * 2010-07-24 2012-10-31 Roche Diagnostics GmbH Stabilization of interleukin 6 in serum based solutions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626572B2 (en) * 1988-07-18 1992-08-06 Chiron Corporation Monoclonal antibodies reactive with cachectin
GB9109645D0 (en) * 1991-05-03 1991-06-26 Celltech Ltd Recombinant antibodies
NZ278607A (en) * 1994-02-07 1999-05-28 Knoll Ag Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above

Also Published As

Publication number Publication date
JP2001521009A (en) 2001-11-06
CN1163272C (en) 2004-08-25
AU756167B2 (en) 2003-01-09
HUP0100105A2 (en) 2001-05-28
NO20001894D0 (en) 2000-04-12
EP1024831A2 (en) 2000-08-09
KR20010024549A (en) 2001-03-26
DE19746868A1 (en) 1999-04-29
CA2306790A1 (en) 1999-05-06
WO1999021582A3 (en) 1999-07-15
WO1999021582A2 (en) 1999-05-06
HUP0100105A3 (en) 2003-08-28
CN1277556A (en) 2000-12-20
NO20001894L (en) 2000-04-12
IL135083A0 (en) 2001-05-20
BR9813114A (en) 2000-08-15
ZA989615B (en) 2000-04-20

Similar Documents

Publication Publication Date Title
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU9028798A (en) Method of improving drug treatment
AU4067697A (en) Therapeutic compositions for treatment of cancer
AU4078997A (en) Cholinesterase inhibitors for treatment of parkinson's disease
AU2388895A (en) Substituted cyclopentadienyl compounds for the treatment of inflammation
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
AU6281599A (en) Alternate day administration of copolymer 1 for treating autoimmune diseases
AU6459596A (en) Methods of treatment of neurological diseases by interferon antagonists
AU3107197A (en) Medicinal compositions for treating liver diseases
AU5884496A (en) Therapeutic sepsis treatment using antagonists to pthrp
AU5623398A (en) Methods of therapeutic administration of anti-cd40l compounds
AU8266798A (en) Cd154 blockade therapy for autoimmune diseases
HUP9903684A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating depression
AU1228499A (en) Application of tnf antagonists as medicaments for treating septic diseases
AU4215499A (en) Treatment of neurodegenerative diseases
AU1562699A (en) Treatment of phosphating waste water
AU5699396A (en) Compositions for the treatment of skin conditions
HUP9801925A3 (en) Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons
AU1405001A (en) Treatment of diseases
AU8817098A (en) Treatment of liquid waste
AU6171196A (en) Therapeutic uses of ta99
AU5854799A (en) Novel treatment of neurodegenerative diseases
AU7772698A (en) Use of indolamines as antithrombotic medicine
AU679162B3 (en) Therapeutic compositions
AU8242398A (en) Medicinal compositions for treating immunodeficiency diseases

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ABBOTT GMBH AND CO. KG

Free format text: THE FORMER OWNER WAS: KNOLL AKTIENGESELLSCHAFT

CB Opposition filed

Opponent name: PROTHERICS PLC

CFC Opposition proceedings - application withdrawn

Opponent name: PROTHERICS PLC

MK12 Application lapsed section 141(1)/reg 8.3(2) - applicant filed a written notice of withdrawal